quinazolines has been researched along with tacrolimus in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 5 (22.73) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, Y; Hisatomi, A; Ishida, H; Mitamura, T; Murato, K; Ohara, K; Takahashi, Y | 1 |
| Basti, S; Benson, A; Lacouture, ME; Patel, J | 1 |
| Asderakis, A; Barten, MJ; Becker, T; Budde, K; Dantal, J; Grinyo, JM; Ng, J; Pietruck, F; Rigotti, P; Sommerer, C; Weber, M | 1 |
| Grenet, O; Kovarik, JM; Seiberling, M; Sfikas, N; Slade, A; Stitah, S; Straube, F; Vitaliti, A; Winter, S | 1 |
| Fang, YH; Jeong, HJ; Joo, DJ; Kim, JY; Kim, MS; Kim, YS; Lim, BJ | 1 |
| Budde, K; Glander, P; Mashreghi, MF; Matz, M; Naik, M; Neumayer, HH | 1 |
| Arns, W; Budde, K; Dantal, J; Grinyo, JM; Kovarik, JM; Proot, P; Rostaing, L; Steiger, JU | 1 |
| Abrams, K; Arns, W; Banas, B; Budde, K; Chan, L; Cibrik, D; Friman, S; Klempnauer, J; Mulgaonkar, S; Nashan, B; Nicholson, M; Vincenti, F; Wahlberg, J; Wissing, KM; Witte, S; Woodle, ES | 1 |
| Fang, YH; Huh, KH; Joo, DJ; Kim, MS; Kim, YS; Lim, BJ; Suh, H | 1 |
| Beckebaum, S; Cicinnati, VR; Kabar, I; Radtke, A | 1 |
| Baan, CC; Kraaijeveld, R; Vafadari, R; Weimar, W | 1 |
| Budde, K; Chodoff, L; Cohney, S; Eris, J; Gill, J; Klupp, J; Kuypers, DR; Langer, RM; Ng, J; Russ, GR; Sommerer, C; Tedesco-Silva, H; von Zur-Mühlen, B; Witzke, O; Woodle, ES | 1 |
| Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
| Bijarnia, M; De Simone, P; Isoneimi, H; Klupp, J; Krishnan, I; Pascher, A; Pirenne, J; Pratschke, J; Salamé, E | 1 |
| Aguiar, W; Campos, E; Cristelli, M; Felipe, C; Ferreira, A; Franco, M; Gerbase de Lima, M; Hannun, P; Medina-Pestana, J; Sandes-Freitas, T; Tedesco-Silva, H | 1 |
| Abumiya, M; Guo, YM; Takahashi, N; Ubukawa, K; Yamashita, T | 1 |
| Adedoyin, A; Cho, CR; Iwamoto, M; Kraft, WK; Levine, V; Liu, F; Macha, S; Marshall, W; McCrea, JB; Menzel, K; Panebianco, D; Stoch, SA; Yoon, E; Zhao, T | 1 |
| Fukunaga, K; Higami, T; Hikasa, S; Ikegame, K; Kaida, K; Kimura, T; Osugi, Y; Shimabukuro, S; Tada, M; Tanaka, K; Yanai, M | 1 |
| Anamisis, A; Choe, JY; Hedvat, J; Kovac, D; Lange, NW; Lee, JH; Liu, EC; Salerno, DM; Scheffert, JL; Shertel, TL | 1 |
| Brown, A; Gupta, G; Kumar, D; Song, C; Thacker, L; Winstead, RJ; Yakubu, I | 1 |
| Aoki, J; Fukuda, T; Furukawa, T; Hashimoto, H; Inamoto, Y; Ito, A; Kim, SW; Nakashima, T; Tanaka, T | 1 |
| Cumpston, A; Dillaman, M; Marciano, KA; Ross, KG; Seago, K; Veltri, L | 1 |
2 review(s) available for quinazolines and tacrolimus
| Article | Year |
|---|---|
Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.
Topics: Calcineurin Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Sirolimus; Tacrolimus; Treatment Outcome | 2011 |
Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors?
Topics: Abatacept; Calcineurin Inhibitors; Everolimus; Humans; Immunoconjugates; Immunosuppression Therapy; Liver Transplantation; Mycophenolic Acid; Precision Medicine; Pyrroles; Quinazolines; Renal Insufficiency; Risk Factors; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2013 |
7 trial(s) available for quinazolines and tacrolimus
| Article | Year |
|---|---|
Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients.
Topics: Adult; Aged; Biopsy; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Tacrolimus; Treatment Outcome | 2010 |
Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses.
Topics: Adult; Area Under Curve; Biomarkers; Calcium; Cell Proliferation; Cross-Over Studies; Drug Interactions; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocytes; Male; Protein Kinase C; Pyrroles; Quinazolines; RNA, Messenger; T-Lymphocytes; Tacrolimus; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Pyrroles; Quinazolines; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
Topics: Adult; Calcineurin Inhibitors; Female; Humans; Kidney Transplantation; Male; Mycophenolic Acid; Protein Kinase C; Pyrroles; Quinazolines; Tacrolimus | 2011 |
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.
Topics: Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Immunosuppressive Agents; Kidney; Kidney Transplantation; Pyrroles; Quinazolines; Retrospective Studies; Tacrolimus; Treatment Outcome | 2013 |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.
Topics: Adult; Aged; Biopsy; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Liver Failure; Liver Transplantation; Male; Middle Aged; Protein Kinase C; Pyrroles; Quinazolines; Tacrolimus; Time Factors; Treatment Outcome | 2015 |
Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
Topics: Acetates; Adolescent; Adult; Aged; Antiviral Agents; Area Under Curve; Cyclosporine; Double-Blind Method; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Quinazolines; Sirolimus; Tacrolimus; Young Adult | 2019 |
13 other study(ies) available for quinazolines and tacrolimus
| Article | Year |
|---|---|
Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
Topics: Administration, Oral; Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glucose Tolerance Test; Glutathione; Immunosuppressive Agents; Insulin; Lens, Crystalline; Male; Quinazolines; Rats; Sodium-Potassium-Exchanging ATPase; Sorbitol; Tacrolimus | 1997 |
The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.
Topics: Algorithms; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dermatologic Agents; Dermatology; Doxycycline; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Eye Diseases; Female; Humans; Interprofessional Relations; Lung Neoplasms; Medical Oncology; Middle Aged; Ophthalmology; Quinazolines; Referral and Consultation; Skin Diseases; Tacrolimus | 2006 |
AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report.
Topics: Animals; Graft Rejection; Graft Survival; Heart Transplantation; Lymphocyte Activation; Male; Myocardial Contraction; Pyrroles; Quinazolines; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocytes; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous | 2010 |
The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
Topics: Acute Disease; Animals; Disease Models, Animal; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Kidney; Liver; Male; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Rats; Rats, Inbred BN; Rats, Inbred Lew; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous | 2011 |
Tacrolimus inhibits NF-κB activation in peripheral human T cells.
Topics: Calcineurin Inhibitors; Cells, Cultured; Cytokines; Humans; Immunosuppressive Agents; NF-kappa B; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Pyrroles; Quinazolines; Signal Transduction; T-Lymphocytes; Tacrolimus | 2013 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Efficacy and Safety of Elective Conversion From Sotrastaurin (STN) to Tacrolimus (TAC) or Mycophenolate (MPS) in Stable Kidney Transplant Recipients.
Topics: Adult; Antibodies; Cohort Studies; Drug Interactions; Drug Substitution; Everolimus; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Pyrroles; Quinazolines; Tacrolimus | 2016 |
Pharmacokinetics of Tacrolimus Coadministered With Letermovir in Allogeneic Hematopoietic Stem Cell Transplantation Patients.
Topics: Acetates; Cyclosporine; Healthy Volunteers; Hematopoietic Stem Cell Transplantation; Humans; Quinazolines; Tacrolimus | 2019 |
Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study.
Topics: Acetates; Adult; Antiviral Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Quinazolines; Retrospective Studies; Tacrolimus; Voriconazole | 2020 |
Managing the significant drug-drug interaction between tacrolimus and letermovir in solid organ transplant recipients.
Topics: Acetates; Drug Interactions; Humans; Immunosuppressive Agents; Organ Transplantation; Pharmaceutical Preparations; Quinazolines; Tacrolimus; Transplant Recipients | 2021 |
Letermovir prophylaxis in solid organ transplant-Assessing CMV breakthrough and tacrolimus drug interaction.
Topics: Acetates; Antiviral Agents; Cohort Studies; Cytomegalovirus; Cytomegalovirus Infections; Drug Interactions; Humans; Organ Transplantation; Quinazolines; Tacrolimus | 2021 |
Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal.
Topics: Acetates; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Quinazolines; Tacrolimus; Voriconazole | 2022 |
Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation Recipients.
Topics: Acetates; Adult; Hematopoietic Stem Cell Transplantation; Humans; Quinazolines; Retrospective Studies; Tacrolimus | 2022 |